Skip to Content
Get key facts and figures about chronic dry eye

Lodoxamide ophthalmic Pregnancy and Breastfeeding Warnings

Lodoxamide ophthalmic is also known as: Alomide

Lodoxamide ophthalmic Pregnancy Warnings

Use is not recommended unless clearly needed. AU TGA pregnancy category: B1 US FDA pregnancy category: B

Animal studies using doses up to 5000 times the normal human dose have failed to reveal evidence of reproductive toxicity. Some manufacturers recommend avoiding use of this drug as a precautionary measure. There are no controlled data in human pregnancy. AU TGA pregnancy category B1: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have not shown evidence of an increased occurrence of fetal damage. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Lodoxamide ophthalmic Breastfeeding Warnings

Some manufacturers suggest a risk to the infant cannot be excluded due to insufficient data and therefore recommend use be avoided.

Caution is recommended Excreted into human milk: Unknown Excreted into animal milk: Unknown Comment: Apply pressure to the tear duct by the corner of the eye for at least 1 minute after eye drop instillation to limit systemic absorption; blot excess solution with tissue.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. "Product Information. Alomide (lodoxamide ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Alomide (lodoxamide ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.